Physician profile
Leonard Bridges
NPI 1225162779
$5,377.75
in general payments reported to CMS, 2019-2025
34 companies · $736 in 2025
The $736 reported for 2025 was more than what 89% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $671 · 2020: $724 · 2021: $1,056 · 2022: $733 · 2023: $798 · 2024: $660 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,193.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $969.92 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $845.11 | 2019-2025 | Mounjaro, Trulicity, Zepbound |
| Janssen Pharmaceuticals, INC | $450.45 | 2019-2023 | Xarelto |
| Abbvie INC. | $425.07 | 2021-2025 | Vraylar |
| Novo Nordisk INC | $349.87 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Supernus Pharmaceuticals, INC. | $311.43 | 2021-2023 | Qelbree |
| Amarin Pharma, INC. | $232.78 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $175.66 | 2019-2024 | Abilify Maintena, Rexulti |
| Pfizer INC. | $170.07 | 2019-2025 | |
| Astellas Pharma US INC | $155.79 | 2020-2025 | Veozah |
| Abbott Laboratories | $138.59 | 2024-2025 | Freestyle Libre, Eterna |
| Globus Medical, INC. | $131.47 | 2025 | Senza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.74 | 2020-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $105.56 | 2019-2025 | Xifaxan |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $94.27 | 2024-2025 | Caplyta |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $68.16 | 2020-2022 | |
| Allergan, INC. | $60.66 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $54.78 | 2019-2021 | |
| Mylan Specialty L.P. | $52.25 | 2021-2023 | Yupelri |
| Glaxosmithkline, LLC. | $50.69 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $48.35 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.65 | 2019-2021 | |
| Amgen INC. | $47.24 | 2021-2024 | Otezla, Repatha |
| Sanofi-Aventis U.S. LLC | $41.56 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.25 | 2022-2023 | |
| Eisai INC. | $34.18 | 2020 | |
| Organon LLC | $27.59 | 2025 | Nexplanon |
| Axsome Therapeutics, INC. | $20.71 | 2023 | Auvelity |
| Jazz Pharmaceuticals INC. | $20.11 | 2019 | |
| Irhythm Technologies, INC. | $19.61 | 2022 | |
| Idorsia Pharmaceuticals US INC | $18.89 | 2023 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $15.43 | 2020 | |
| Dexcom, INC. | $15.38 | 2021 | |
| Antares Pharma, INC. | $13.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Bridges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.